Marco Russo
Cancer metabolism is characterized by a series of biochemical changes
that allow malignant cells to sustain rapid growth and proliferation. Central
to these changes are metabolites, which serve as both substrates and
signaling molecules that drive tumour igenesis. This article explores the
role of metabolites in cancer metabolism, focusing on key pathways such
as glycolysis, the tricarboxylic acid (TCA) cycle, and the Pentose Phosphate
Pathway (PPP). We also discuss the implications of metabolite alterations
in tumour igenesis, their potential as biomarkers, and therapeutic targets.
Understanding these metabolic adaptations offers insight into cancer
biology and highlights opportunities for novel treatment strategies.
